The term "dermatitis" (synonym: eczema) refers to a non-infectious, inflammatory disorder of the skin. There are different forms of dermatitis including seborrhoeic dermatitis (infantile and adult types), primary irritant dermatitis, allergic contact dermatitis, dermatitis associated with venous hypertension, dyshidrotic dermatitis (synonym: idiopathic vesicular dermatitis of the hands and feet), photoallergic dermatitis, HIV-associated dermatitis, nummular dermatitis and atopic dermatitis (AD). Atopic dermatitis is common and is the only form of dermatitis that may affect virtually the entire lifespan of an individual. 
Incidence
The incidence of AD in adults in South Africa is unknown. A study conducted in Cape Town among schoolchildren 13-14 years old found a one-year prevalence rate of 8.3% which increased to 13.3% on follow up. In 3-11-year-old Xhosa children a one-year prevalence rate of 1-2.5% was documented. In Western Europe and Australia up to 20% of children develop AD.
Onset
In 70% of cases AD starts in childhood before the age of five years. About 10% of cases seen in hospital settings start in adults. Asthma develops in 30% of children with AD and allergic rhinitis in 35%.
Cause
Atopic dermatitis is a complex disease relying on the interplay of several factors. The disease is familial with polygenic inheritance. A number of suspected gene loci have been identified. Genetics alone cannot explain the increase of AD in smaller families and in higher social classes. Allergic factors such as house-dust mite (HDM), food allergens and pseudoallergens such as citrus fruit and food additives are implicated in some cases. Non-allergic factors are also involved and include Staphylococcus aureus infection, bacterial superantigens, rough clothing, exposure to microbes during infancy, excessive heat and sweating, dry air and irritants that disrupt the barrier function of the skin. Emotional stress is a common flare factor in AD. There appear to be two different types of AD: extrinsic AD (80% of cases, elevated total serum IgE, polyvalent type 1 sensitisation [children against foods and adults against pollens and HDM],CD4 lymphocytes predominate); and intrinsic AD (20% of cases, total serum IgE normal, polyvalent type 1 sensitisation absent, CD8 lymphocytes predominate). The concept is currently controversial.
Clinical features
Criteria for the diagnosis of AD are listed in Table I and minor diagnostic  features in Table II . The experienced clinician always looks for DenneMorgan lines (infraorbital skin creases), periorbital darkening, circumoral pallor, keratosis pilaris (follicular keratotic papules and papulopustules on the arms and thighs), ichthyosis vulgaris (autosomal dominant, fine scaling most prominent on the lower legs and buttocks), pityriasis alba (whitish, round, dry patches with fine scaling) and other minor features which in children are often pointers to atopy.
The rash is chronic and intensely pruritic. The clinical pattern varies at different stages of life. In infants the entire skin surface with the exception of the nappy area may be involved. In children the face is commonly involved and in adolescents the flexures. In adults the hands and nape are preferential areas.
All forms of dermatitis essentially show similar features and are pruritic. Pruritus induces scratching and rubbing. A video of the typical scratching pattern is available at www.safpj.co.za. Acute dermatitis is characterised by erythema, oedema, vesiculation, oozing and crusting. The main microscopic features are acanthosis and variable intercellular oedema, spongiosis. Chronic dermatitis shows leathery thickening of the skin. The skin is dry, scaly and commonly fissured. Microscopy shows compact orthokeratosis, acanthosis and collagen in vertical streaks in the papillary dermis. Subacute dermatitis is red or brown and scaly. Microscopy displays acanthosis and mild spongiosis. All forms show a lymphocytic infiltrate of variable density.
Clinical findings are depicted in Figures 1-8 .
The diagnosis and management of atopic dermatitis 10. Eye examination is indicated in some cases.
Complications
One of the complications is the so-called allergic march. A percentage of patients with AD progress to allergic asthma and eventually rhinitis.
There is some evidence to suggest that cetirizine hydrochloride may retard this process.
An extremely common complication of AD is periodic exacerbation of the disease. These flares may arise spontaneously or may be precipitated by irritation of the skin, bacterial superinfection, superimposed allergic contact dermatitis and stress.
The dermatitis may become widespread involving more than 90% of the body surface area. This is known as erythroderma. Erythroderma impairs quality of life and may cause disturbance of thermoregulation.
Electrolytes, protein, water and minerals are lost transepidermally. The risk of superinfection is high. Erythroderma may arise spontaneously or be precipitated by irritation of the skin.
Bacterial superinfection, usually in the form or superficial, or superficial and deep folliculitis, impetigo or ecthyma, is common. Pruritus and subsequent scratching impairs the skin barrier paving the way for infection. Staphylococcus aureus is the commonest cause, but group A beta-haemolytic streptococci (GABHS) may also be culprits. Infection with certain serotypes of GABHS may be complicated by glomerulonephritis.
Erysipelas and cellulitis are less commonly encountered.
Herpes simplex virus infection is not uncommon. The infection may become widespread on a background of dermatitis associated with constitutional symptoms known as Kaposi's varicelliform eruption (synonym: eczema herpeticum). Acyclovir, intravenously in severe cases, is indicated. These patients are also more prone to develop molluscum contagiosum which is caused by MC viruses. The lesions are pearly white papules and central umbilication is commonly present. The lesions may be few or numerous.
Dermatophyte infections are more common in AD, the so-called ADdermatophyte syndrome.
In some patients with AD the disease may be exacerbated by exposure to sunlight.
Atopic dermatitis impairs quality of life creating social and occupational problems. Sleep disturbance due to itching and scratching is troublesome.
Allergic contact dermatitis may be superimposed on AD. In any patient not responding to appropriate treatment the possibility of underlying allergic contact dermatitis should be contemplated and patch tests done.
Differential diagnosis
Conditions to be considered in the differential diagnosis are listed in Table  III . The differential diagnosis will depend on the age of the patient and the location of the dermatitis. The classic features of flexural, facial or nuchal dermatitis are extremely typical and can be diagnosed at a glance. In infants, infantile seborrhoeic dermatitis is in the differential diagnosis. Distinction may be very difficult. Infantile seborrhoeic dermatitis tends to appear before six months of age and AD after six months of age. Infants with seborrhoeic dermatitis appear contented and pruritus and scratching are often absent. The napkin area is commonly involved. In AD this area is often spared. Postinflammatory hypopigmentation is more common than in AD. Infantile seborrhoeic dermatitis has an excellent prognosis and usually resolves spontaneously by two years. Flares are unusual. Sometimes the distinction can only be made as the child grows older. Psoriasiform AD must be distinguished from psoriasis.
Treatment
No disease is more complicated to treat than AD. It is essential to work with the patient and parents and they should be made part of the management team. Listening attentively to their observations is important. Do not decide whether the patient needs an ointment or cream. Ask the patient what he or she prefers -cream or ointment. Adherence to topical treatment is vital in the management of these patients. Adherence can be improved by handing out written instructions, by limiting the prescription, and by scheduling a follow-up visit shortly after initiating topical treatment. Electronic monitoring systems are used in some countries. Delivery of text messages via mobile phones may be helpful. Topical medications can be applied once daily leading to improved adherence. Twice-daily application of topical drugs does not improve outcomes. Steroidophobia should be addressed.
Topical therapy
Frequent applications of emollient creams or ointments are vitally important. The patient should determine, often by trial and error, which of these are most suitable. Although the dry skin of AD usually benefits from an ointment, there are many exceptions to the rule. A soap substitute (such as Epizone A or E) is equally important. There is currently no evidence to doubt that regular emollient use is beneficial for the treatment of the dry skin associated with AD. There is no clear randomly controlled trial (RCT) evidence of their benefit. Whether bath additives provide additional benefit is particularly unclear. Bubble baths, foaming soap and shampooing while bathing are not recommended. The temperature of the bath should be neither too hot nor too cold. Rough texture towels should not be used and the skin should be dabbed rather than rubbed dry.
Topical anti-inflammatory agents

Topical corticosteroids
Topical corticosteroids (CS) are an extremely important treatment modality in patients with AD. Potent steroids are reserved for flares and should be applied for a limited period of time. Once-daily application is adequate. These agents should never be applied Circular "cracked" areas of erythema one to five cm in diameter are present initially on the limbs, often with secondary infection. In children, discoid eczema is most commonly associated with atopic dermatitis and is often confused with tinea (ringworm). In adults, it may be associated with excessive skin dryness and secondary infection with Staphylococcus aureus.
Irritant contact dermatitis
Cumulative damage to the skin barrier from irritants such as soaps and detergents is present. The clinical appearance can be identical to that of atopic dermatitis, but location at sites of maximal exposure (e.g. fingers) may be helpful in making the diagnosis. Some degree of irritant contact dermatitis is common in persons with atopic dermatitis (e.g. in babies, around the mouth, owing to saliva and wet food, and in the diaper area, owing to urine).
Allergic contact dermatitis
A hypersensititivy reaction exists after sensitisation to specific substances (e.g. the nickel in jewelry, the rubber in gloves, or the glues in some shoes). Localisation may suggest this diagnosis, but patch tests are needed to definitely establish it. This diagnosis may coexist with atopic dermatitis.
Frictional lichenoid dermatitis
Shiny papules occur at elbows, knees and backs of hands probably related to friction. The diagnosis may be common, and may be more so in patients with atopic dermatitis.
Other exogenous skin conditions Scabies
Infestation may produce nonspecific eczematous changes on the entire body. Burrows and pustules on palms, soles, genitalia and between fingers help to establish diagnosis.
Onchocerciasis
The chronic phase may be accompanied by widespread itching and lichenification of the skin similar to that seen in cases of chronic atopic dermatitis.
Insect bites Secondary eczematous changes may develop in the area of the bites, especially on the limbs, and may be confused with atopic dermatitis.
*Adapted from Williams et al more than twice daily. In the absence of flares less potent products suffice. Steroid no-go areas include the face and flexures. Thinning (atrophy) of the skin is the main side-effect. It is not possible to make recommendations about the "best" topical CS as no RCT has compared all the available preparations of similar potency. In adults and children it has been shown that twice-weekly application of a potent topical CS can prevent flare-ups following stabilisation of the eczema. Such data is not available for infants. Skin thinning is not a major problem if the drug is used correctly.
Topical immunomodulators
The calcineurin inhibitors (CNI) are newer agents for the treatment of AD. Pimecrolimus cream 1% (Elidel ® ) is indicated for mild AD (mild AD: < 5% of BSA involved, no acute changes, no impairment on quality of life [QOL] ). Pimecrolimus cream works better than vehicle cream. The cream can be used in steroid sensitive areas such as the face and skin folds. The cream is less effective than betamethasone valerate (Betnovate ® ) in AD.
Tacrolimus ointment 0.03 and 0.1% (Protopic ® ) is indicated for moderate (5-30% of BSA involved, acute changes on presentation, significant impairment of QOL) and severe AD (> 30% of BSA involved, acute lesions, severe impairment on QOL), and for maintenance of treatment following induction of remission by topical CS. The 0.03% product can be used in children older than two years and the 0.1% ointment in those older than 15 years. The ointment is applied twice daily until remission occurs and is thereafter tapered. Tacrolimus ointment works better than vehicle cream.
Both preparations are more potent than 1% hydrocortisone. The 0.1% preparation is equivalent in efficacy to potent topical CS such as hydrocortisone butyrate and betamethasone valerate. Transient burning occurs in about half of adults but is seldom of sufficient degree to stop the drug. The risk of skin infection, systemic infection and internal cancers remains to be determined. The cost-effectiveness of the CNI and potent topical CS has not been compared. In children tacrolimus should be used if short bursts of a potent topical CS, emollients and educational support have failed.
Tars are available as creams or mixed-in ointments and may be of some value in lichenified lesions.
Antiseptics (such as triclosan 1-3% cream) may be added to the bath to lessen staphylococcal colonisation. The level of evidence is low. Topical application of these agents is not recommended.
Systemic treatment
1. Antihistamines can be used for severe pruritus. Sedating drugs work much better. The nonsedating drugs are rather ineffective. It is postulated that cetirizine hydrochloride is anti-inflammatory and may curtail the atopic march. 2. Ciclosporin is indicated for severe refractory AD. 3. Oral corticosteroids are indicated for severe refractory AD. 4. Azathioprine is indicated for severe refractory AD.
Ciclosporin, oral corticosteroids and azathioprine have side-effects and should be used for short-term to medium-term periods during major disease flares, with a return to conventional treatment once control is maintained. 5. Flares of AD may be caused by S. aureus and appropriate antibiotic treatment is perhaps of benefit. 6. UVA1 (340-400 nm) is reasonably effective for acute flares and narrowband UVB (311 nm) better for chronic disease.
The efficacy of unsaturated fatty acids is unclear. No RCTs have been conducted on methotrexate, mycophenolate mofetil or biologic therapies.
Non-pharmacological measures
It is important to avoid triggers such as wool or nylon clothing, fabric softeners and work that requires frequent hand washing. The roughness of clothing textiles is a more important factor for skin irritation than the type of textile fibre (synthetic or natural). Polyester and cotton of similar textile fineness seem to be equally well tolerated. Dust, unfamiliar pets, sweating and shampoos may play a direct role in worsening AD.
If relevant type 1 allergens are identified, these should be avoided. These include pollens and HDM. HDM can be reduced by allergenimpermeable mattresses and pillow covers and regular vacuuming of the room. Whether these measures contribute to the control of AD is currently controversial. Vacation at high altitude may be beneficial. HDM cannot live above 1 500 m perhaps explaining the effectiveness of high altitude vacation.
An elimination diet is indicated only if type 1 allergy is proven. There is some evidence to support the use of an egg-free diet in those with a specific IgE to eggs. There is no evidence to support the use of an elemental or few-foods diet in AD. A pseudoallergen-free diet may be helpful if clinically suggested. The routine use of restricted diets in infants with AD is strongly discouraged. There is certainly a risk of impaired growth and development.
Three RCTs suggest that psychological interventions such as habitreversal techniques are useful as adjunct to dermatological treatment of AD.
There is no strong evidence of a protective effect of exclusive breastfeeding for at least three months against the development of AD even amongst children with a positive family history.
Course
Approximately 60% of patients with childhood AD are free of symptoms in early adolescence. Up to 50% of cases may have recurrences in adulthood. A more persistent course is predicted by early-onset disease, severe early disease, concomitant asthma and hay fever and a family history of AD.
Summary
Atopic dermatitis is a common skin disease that has a formidable impact on the QOL of the suffering individual. By correctly diagnosing and treating AD this situation may be ameliorated. Hopefully this manuscript will provide practising clinicians with guidelines to achieve optimisation of the management of patients with AD.
Further reading
